![HealthTree Podcast for Multiple Myeloma artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts113/v4/8f/ab/bd/8fabbdcd-0da0-0239-dac5-df547f82810a/mza_6724809222047263023.jpg/100x100bb.jpg)
HealthTree Podcast for Multiple Myeloma: Syed Abbas Ali, MD, Johns Hopkins
HealthTree Podcast for Multiple Myeloma
English - October 16, 2020 19:00 - 1 hour - 75.9 MB - ★★★★★ - 13 ratingsHealth & Fitness myeloma multiple myeloma Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Myeloma Crowd: Syed Abbas Ali, MD, Johns Hopkins
Dr. Ali is the primary investigator on a clinical trial to use a vaccine to extend remissions following successful myeloma treatment. The GVAX study is open for patients who are MRD positive but don't yet have a measurable m-protein. Dr. Ali explains how the vaccine works and why patients may want to use it to lengthen theri remission times.
Thanks to our episode sponsor, Bristol Myers Squibb.